SCHRODER INVESTMENT MANAGEMENT GROUP - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$30,913,676
-3.0%
2,513,307
+26.7%
0.05%0.0%
Q2 2023$31,884,953
-21.5%
1,984,129
-14.9%
0.05%
-23.3%
Q1 2023$40,607,676
+90.9%
2,332,434
+1.3%
0.06%
+76.5%
Q4 2022$21,274,056
+43.0%
2,302,387
+33.3%
0.03%
+36.0%
Q3 2022$14,874,000
-20.5%
1,727,572
-24.7%
0.02%
-13.8%
Q2 2022$18,710,000
-35.8%
2,295,683
-4.3%
0.03%
-25.6%
Q1 2022$29,151,000
-53.7%
2,399,238
+30.0%
0.04%
-52.4%
Q4 2021$62,993,000
+29.5%
1,846,219
+83.2%
0.08%
+9.3%
Q3 2021$48,625,0001,007,9910.08%
Other shareholders
NEOGENOMICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Kopp Family Office, LLC 1,046,639$12,8748.15%
Greenhouse Funds LLLP 3,981,003$48,966,3373.62%
First Light Asset Management, LLC 3,028,913$37,255,6303.54%
PERKINS CAPITAL MANAGEMENT INC 193,950$2,3862.36%
EMERALD MUTUAL FUND ADVISERS TRUST 1,557,895$19,162,1091.16%
EMERALD ADVISERS, LLC 1,927,074$23,703,0051.15%
Bullseye Asset Management LLC 163,792$2,0151.12%
FORMULA GROWTH LTD 208,885$2,569,2860.88%
OAK FAMILY ADVISORS, LLC 96,737$1,189,8650.56%
Parkman Healthcare Partners LLC 245,812$3,023,4880.55%
View complete list of NEOGENOMICS INC shareholders